Genetic variants linked to T2DM risk in Kurdish populations

Shadi Golsheh,1 Fatemeh Keshavarzi21Department of Biology, Kurdistan Science and Research Branch, Islamic Azad University, Sanandaj, Iran; 2Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, IranBackground: The polymorphisms of the C–C chemokine receptor type 5 (CCR...

Full description

Bibliographic Details
Main Authors: Golsheh S, Keshavarzi F
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
Online Access:https://www.dovepress.com/genetic-variants-linked-to-t2dm-risk-in-kurdish-populations-peer-reviewed-article-DMSO
id doaj-6d71b290b6fc4dfe87d7f0a95dc50d2e
record_format Article
spelling doaj-6d71b290b6fc4dfe87d7f0a95dc50d2e2020-11-25T02:33:53ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy1178-70072019-04-01Volume 1243143744951Genetic variants linked to T2DM risk in Kurdish populationsGolsheh SKeshavarzi FShadi Golsheh,1 Fatemeh Keshavarzi21Department of Biology, Kurdistan Science and Research Branch, Islamic Azad University, Sanandaj, Iran; 2Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, IranBackground: The polymorphisms of the C–C chemokine receptor type 5 (CCR5) and the insulin receptor substrate 1 (IRS1) have been studied as candidates for the susceptibility to develop type 2 diabetes mellitus (T2DM). CCR5 is a chemokine receptor, and the polymorphisms in the promoter region of this receptor are being studied as candidates for the susceptibility to develop T2DM. Also, IRS1 is a critical factor in the signaling pathway for insulin, and mutations in this gene have been reported, which contribute to the ability to develop T2DM. The aim of the current study was to determine the relationship between CCR5 (59029A/G) and IRS1 (rs10498210) polymorphisms with T2DM in Sanandajian patients.Methods: Genomic DNA was isolated from 200 healthy individuals and 220 Kurdish T2DM patients by salt extraction method and the polymorphisms were examined by restriction fragment length polymorphism (RFLP) method and then the results were analyzed using Chi-square test.Results: The frequency of AA genotype in 220 Kurdish patients for both genes CCR5 (OR=1.9, P=0.02) and IRS1 (OR [95% CI]=2.62, P=0.02) were significantly more than controls. There was no significant association between AG or GG genotypes in with T2DM.Conclusion: The presence of AA homozygote alleles in both loci of IRS1 (rs10498210) and CCR5 (59029A/G) genes increased the risk of T2DM.Keywords: IRS1 (rs10498210), CCR5 (59029A/G), type 2 diabetes, Kurdish patientshttps://www.dovepress.com/genetic-variants-linked-to-t2dm-risk-in-kurdish-populations-peer-reviewed-article-DMSOIRS1 (rs10498210)CCR5 (59029A/G)Type 2 diabetesKurdish patients
collection DOAJ
language English
format Article
sources DOAJ
author Golsheh S
Keshavarzi F
spellingShingle Golsheh S
Keshavarzi F
Genetic variants linked to T2DM risk in Kurdish populations
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
IRS1 (rs10498210)
CCR5 (59029A/G)
Type 2 diabetes
Kurdish patients
author_facet Golsheh S
Keshavarzi F
author_sort Golsheh S
title Genetic variants linked to T2DM risk in Kurdish populations
title_short Genetic variants linked to T2DM risk in Kurdish populations
title_full Genetic variants linked to T2DM risk in Kurdish populations
title_fullStr Genetic variants linked to T2DM risk in Kurdish populations
title_full_unstemmed Genetic variants linked to T2DM risk in Kurdish populations
title_sort genetic variants linked to t2dm risk in kurdish populations
publisher Dove Medical Press
series Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
issn 1178-7007
publishDate 2019-04-01
description Shadi Golsheh,1 Fatemeh Keshavarzi21Department of Biology, Kurdistan Science and Research Branch, Islamic Azad University, Sanandaj, Iran; 2Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, IranBackground: The polymorphisms of the C–C chemokine receptor type 5 (CCR5) and the insulin receptor substrate 1 (IRS1) have been studied as candidates for the susceptibility to develop type 2 diabetes mellitus (T2DM). CCR5 is a chemokine receptor, and the polymorphisms in the promoter region of this receptor are being studied as candidates for the susceptibility to develop T2DM. Also, IRS1 is a critical factor in the signaling pathway for insulin, and mutations in this gene have been reported, which contribute to the ability to develop T2DM. The aim of the current study was to determine the relationship between CCR5 (59029A/G) and IRS1 (rs10498210) polymorphisms with T2DM in Sanandajian patients.Methods: Genomic DNA was isolated from 200 healthy individuals and 220 Kurdish T2DM patients by salt extraction method and the polymorphisms were examined by restriction fragment length polymorphism (RFLP) method and then the results were analyzed using Chi-square test.Results: The frequency of AA genotype in 220 Kurdish patients for both genes CCR5 (OR=1.9, P=0.02) and IRS1 (OR [95% CI]=2.62, P=0.02) were significantly more than controls. There was no significant association between AG or GG genotypes in with T2DM.Conclusion: The presence of AA homozygote alleles in both loci of IRS1 (rs10498210) and CCR5 (59029A/G) genes increased the risk of T2DM.Keywords: IRS1 (rs10498210), CCR5 (59029A/G), type 2 diabetes, Kurdish patients
topic IRS1 (rs10498210)
CCR5 (59029A/G)
Type 2 diabetes
Kurdish patients
url https://www.dovepress.com/genetic-variants-linked-to-t2dm-risk-in-kurdish-populations-peer-reviewed-article-DMSO
work_keys_str_mv AT golshehs geneticvariantslinkedtot2dmriskinkurdishpopulations
AT keshavarzif geneticvariantslinkedtot2dmriskinkurdishpopulations
_version_ 1724811762721619968